CS2009 is a promising trispecific antibody targeting PD-1, VEGFA, and CTLA-4, which demonstrates broad clinical application prospects for solid tumors with the great potential to become the ...

mice that were administered anti-CD11b neutralizing antibody or agonist leukadherin-1. Blood pressure was monitored with tail-cuff method and radiotelemetry. Blood and vascular inflammatory cells were ...

F. Short‐term killing assay of AB + ‐serum opsonized (AB + serum) and non‐opsonized iRBCs (no serum) in the presence of anti‐ICAM1 blocking antibody (mAb 15.2) and anti‐CD11b control antibody.

G, H. Phagocytosis is measured by flow cytometry. After co‐incubation, BMDMs were stained with fluorochrome‐conjugated anti‐CD11B antibody and analyzed through flow cytometry. Phagocytosing efficiency ...

Paraffin-embedded knee sections were stained with CD11b antibody (133357, Abcam). MMP13 was detected with anti-MMP13 (Ab39012 from Abcam), and quantified by calculating positive cells by use of Image ...

A rabbit monoclonal anti-human CD11b antibody (clone EP1345Y, Abcam) was used for IHC staining of CD11b. Tissues were quantified with Aperio ImageScope software (Leica) using an algorithm in HALO ...

before CD11b levels or phagocytic capacity was assessed. Since human GM-CSF and mouse GM-CSF are not immunologically cross-reactive, for in vivo studies, monoclonal anti–mouse GM-CSF antibody ...